The Hep C Field Gets Nastier By the Minute -- @Liber8 @Gilead
... Gilead is, naturally, suing Abbvie
over this as well, saying that Abbvie has knowing mispresented to the
USPTO that they invented the Gilead therapies. I'm not sure how that's
going to play out: Abbvie didn't have to invent the drugs to get a
method-of-use patent on them. At the same time, I don't know what sort
of enablement Abbvie's patent claims might have behind them, given that
these are, well, Gilead's compounds. The company is apparently claiming
that a "sophisticated computer model" allows them to make a case that
these combinations would be the effective ones, but I really don't know
if that's going to cut it (and in fact, I sort of hope it doesn't). But
even though I'm not enough of a patent-law guy to say either way, I'm
enough of one to say, with great confidence, that this is going to be a
very expensive mess to sort out. Gilead's also in court with Merck (and
was with Idenix before Merck bought them), and with Roche, and will
probably be in court with everyone else before all this is over. ...
Pricey life-saving drugs hold patients captive
http://www.usatoday.com/story/opinion/2014/07/20/hepatitis-c-drugs-gilead-sciences-your-say/12914795/
Lucrative Drug Niche Sparks Legal Scramble
Battle Escalates for Dominance in Treatments for Hepatitis C
No comments:
Post a Comment